All about the fund UBS Lux Equity Fund Biotech USD P-acc, which stocks or funds the fund owns, and how much the fund owns of each holding.
Details
Security
UBS Lux Equity Fund Biotech USD P-acc
Fee
2,25%
ISIN
LU0069152568
Currency
USD
Holdings
5
Recent performance of UBS Lux Equity Fund Biotech USD:
| 1M | 1.69% |
| 3M | -11.17% |
| YTD | -6.38% |
Find funds with similar holdings as UBS Lux Equity Fund Biotech USD here:
| Security | Fee | ||
|---|---|---|---|
1 |
SEB Bioteknikfond D EUR Lux Utd The fund's holdings match to 60% The fund's fee of 1,69% is 0,56 lower Annual Dividend |
(i) | |
| 2 |
Avanza Healthcare by Samuelsson & Hult The fund's holdings match to 40% The fund's fee of 1,25% is 1 lower |
(i) | |
The fund UBS Lux Equity Fund Biotech USD P-acc has 7 holdings, with the largest being Regeneron Pharmaceuticals at 10.04%, followed by Moderna at 9.21% and Gilead Sciences at 4.66%.
Here are all holdings in UBS Lux Equity Fund Biotech USD:
| # | Security | Share | ||
|---|---|---|---|---|
| 1 | US75886F1075 |
(i) | ||
| 2 | US60770K1079 |
(i) | ||
| 3 |  |
US3755581036 |
(i) | |
| 4 | US09075V1026 |
(i) | ||
| 5 | US48576A1007 |
(i) | ||
4.7% of the fund's holdings are from USA.
| Gilead Sciences Inc 4.66% |
The list of fund holdings was last updated on September 7, 2025.
Compare UBS Lux Equity Fund Biotech USD P-acc with other funds to see how the allocation differs.
